Investor Relations
Financial calendar
2024 Annual Report
01/05/25Q1 report
15/05/25Annual General Meeting
28/05/25Half-year report
21/08/25Q3 report
13/11/25Full-year report
05/02/26Annual Report for 2025
05/05/26
Latest press releases
Notice to attend the Annual General Meeting in ExpreS2ion Biotech Holding AB (publ)
N.B. This notice has been prepared in both Swedish and English language versions. In the event of any discrepancies between the versions, the Swedish version shall prevail. The shareholders of ExpreS2ion Biotech Holding AB (publ), reg. no. 559033-3729 (the "Company"), are hereby given notice to attend the Annual General Meeting to be held on 28…
Read moreKallelse till årsstämma i ExpreS2ion Biotech Holding AB (publ)
Aktieägarna i ExpreS2ion Biotech Holding AB (publ), org.nr 559033-3729 ("Bolaget"), kallas härmed till årsstämma den 28 maj 2025 klockan 10.30 på Mindpark, Bredgatan 11, i Helsingborg. Inpassering och registrering till stämman startar klockan 10.00.
Read moreExpreS2ion signs Letter of Intent with WuXi Vaccines to initiate technology evaluation of ExpreS2ion’s proprietary production platform ExpreS2™
Hørsholm, Denmark, 15 April 2025 - ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), today announced that ExpreS2ion and WuXi Vaccines have signed a Letter of Intent to initiate a technology evaluation of ExpreS2ion’s proprietary Drosophila S2 expression technology platform (“ExpreS2”) for the bioproduction of vaccines and other biologics. WuXi Vaccines is a World-leading…
Read moreLatest presentations
2024 Q4 and Full-Year
Report Webcast
6 February 2025
Stora Aktiedagarna
Stockholm
27 November 2024
Biostock
Life Science Summit
21 November 2024